Author(s):
Ahmed Salim Mahmood, Altalebi Raghid Reyadh, Basman Q. Shareef, Ali H. Albu-Rghaif, Hany A. Al-hussaniy, Meena Akeel Naji
Email(s):
Hany_akeel2000@yahoo.com
DOI:
10.52711/0974-360X.2023.00218 
Address:
Ahmed Salim Mahmood1, Altalebi Raghid Reyadh2, Basman Q. Shareef3, Ali H. Albu-Rghaif3, Hany A. Al-hussaniy2,4*, Meena Akeel Naji6
1Department of Pharmacy, Al-Rasheed University, Baghdad, Iraq.
2Department of Family Physician (CCFP), Madigan Medical Centre, Calgary, Alberta, Canada.
3Department of Pharmacy, Ashur University Collage, Baghdad, Iraq.
4Department of Pharmacy, Bilad Alrafidain University College, Diyala Junction, Baqubah, Diyala, Iraq.
5Department of Medicinal Chemistry, Collage of Pharmacy, Ashur University, Baghdad, Iraq.
6Department of Family Physicians' Collage of Medicine University of Baghdad, Iraq.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2023
ABSTRACT:
Introduction: The family history of thyroid disease (FHTD), which is either hyper or hypothyroidism, and its effect and the association with other diseases such as autoimmune disease or genetic diseases such as Down syndrome are not well understood, especially in countries in the middle east such as Iraq, which makes studies of this type get some interest recently and the correlation should be understood. Objective: To find out if there is an association between down syndrome and a family history of thyroid disorder. Methods: 451 New born babies have been enrolled in the studies. However, 4 of them has been excluded due to inadequate information; the result is about 396 collected in two hospital public (free serves) and privet hospital here in Iraq. The thyroid test and its family history information were collected in 67 new borns with down syndrome with a family history of thyroid dysfunction and the second group of 329 new borns with down syndrome without a family history of thyroid dysfunction, using the SPSS program to study the correlation confidence interval, and other logical analysis were performed in studies. Results: about sixteen neonates suffered from thyroid percent of about 4.1%, 9-Newborn's with down syndrome in this study had congenital hypothyroidism (4.1%). However, our research shows a correlation between a patient suffering from thyroid dysfunction with Down syndrome (Adjusted odds ratios= 8.3, 95% CI 2.0-34.3), moreover, the result slightly changes in males (Adjusted odds ratios= 9.0, 95% CI: 1.6-49.6). However, all the neonates with down syndrome had a low incidence of thyroid dysfunction if they have no family history of thyroid dysfunction (Adjusted odds ratios= 0.4, 95% CI: 0.1-0.8). In conclusion, we confirm the association between congenital hypothyroidism and FHTD in babies with DS. Babies with DS with FHTD have an eight-time higher risk of congenital hypothyroidism, particularly those of the male sex.
Cite this article:
Ahmed Salim Mahmood, Altalebi Raghid Reyadh, Basman Q. Shareef, Ali H. Albu-Rghaif, Hany A. Al-hussaniy, Meena Akeel Naji. Increasing Prevalence of Congenital Hypothyroidism in children with Down Syndrome who have a family history of Thyroid disease. Research Journal of Pharmacy and Technology 2023; 16(3):1327-2. doi: 10.52711/0974-360X.2023.00218
Cite(Electronic):
Ahmed Salim Mahmood, Altalebi Raghid Reyadh, Basman Q. Shareef, Ali H. Albu-Rghaif, Hany A. Al-hussaniy, Meena Akeel Naji. Increasing Prevalence of Congenital Hypothyroidism in children with Down Syndrome who have a family history of Thyroid disease. Research Journal of Pharmacy and Technology 2023; 16(3):1327-2. doi: 10.52711/0974-360X.2023.00218 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2023-16-3-54
REFERENCES:
1. Trotsenburg A, Kempers M, Endert E, Tijssen J, Vijlder J, Vulsma T. Trisomy 21 Causes Persistent Congenital Hypothyroidism Presumably of Thyroidal Origin. Thyroid. 2006; 16(7):671-680.
2. Abbassi V, Adams J, Duvall D, Phillips E. Prenatal Thyroid Function Abnormalities in Infants with Idiopathic Respiratory Distress Syndrome. Pediatric Research. 1984; 18(10):926-928.
3. A van W, Kok J. Thyroid Function and Thyroid Hormone Requirements of Very Preterm Infants. NeoReviews. 2000; 1(6): 116e-121.
4. Purdy I, Singh N, Brown W, Vangala S, Devaskar U. Revisiting early hypothyroidism screening in infants with Down syndrome. Journal of Perinatology. 2014; 34(12): 936-940.
5. Andersen S, Olsen J. Early Pregnancy Thyroid Function Test Abnormalities in Biobank Sera from Women Clinically Diagnosed with Thyroid Dysfunction Before or After Pregnancy. Thyroid. 2017; 27(3): 451-459.
6. Kariyawasam D, Carr A, Luton D, Polak M. Down Syndrome and Nonautoimmune Hypothyroidisms in Neonates and Infants. Hormone Research in Paediatric. 2015; 83(2):126-131.
7. Prasher V \, S N, S. H. Fifteen-year follow-up of thyroid status in adults with Down syndrome. Journal of Intellectual Disability Research. 2011; 55(4):392-396.
8. Fialkow P, Hecht F, Uchida I, Motulsky A. Increased frequency of thyroid autoantibodies in mothers of patients with down's syndrome. The Lancet. 1965; 286(7418):868-870.
9. Park E, Yoon.J.. Factors associated with permanent hypothyroidism in infants with congenital hypothyroidism. BMC Pediatrics. 2019; 19(1).
10. Corona‐Rivera J, Martínez‐Macías F, Bobadilla‐Morales L, Corona‐Rivera A, Peña‐Padilla C, Rios‐Flores. Prevalence and risk factors for Down syndrome: A hospital‐based single‐center study in Western Mexico. American Journal of Medical Genetics Part A. 2019; 179(3):435-441.
11. Chanoine J. Selenium and thyroid function in infants, children and adolescents. BioFactors. 2003; 19(3-4): 137-143.
12. Fadeev V. Comments to guidelines for the treatment of hypothyroidism prepared by the American thyroid association task force on thyroid hormone replacement. Clinical and experimental thyroidology. 2015; 10(4): 9.
13. Bennett R, Steinhaus K, Uhrichm S, O'Sullivan C. The need for developing standardized family pedigree nomenclature. Journal of Genetic Counseling. 1993; 2(4): 261-273.
14. Hinton C, Harris K, Borgfeld L, Drummond-Borg M, Eaton R, Lorey F, et al. Trends in Incidence Rates of Congenital Hypothyroidism Related to Select Demographic Factors: Data from the United States, California, Massachusetts, New York, and Texas. Pediatrics. 2010; 125(Supplement 2): S37-S47.
15. Jaruratanasirikul S, Patarakijvanich N, Patanapisarnsak C. The Association of Congenital Hypothyroidism and Congenital Gastrointestinal Anomalies in Down's Syndrome Infants. Journal of Pediatric Endocrinology and Metabolism. 1998; 11(2): 9.
16. Amiri M, NaderiLordejani M, Askarpour H, Yahyapour R, Bastam D, Mahmoodi E, et al. Epidemiology of neonatal congenital hypothyroidism during 2011-2017. Journal of critical reviews. 2020; 7(02).
17. van T, Vulsma T, vanSanten H, Cheung W, deVijlder J. Lower Neonatal Screening Thyroxine Concentrations in Down Syndrome Newborns. The Journal of Clinical Endocrinology and Metabolism. 2003; 88(4):1512-1515.
18. Erlichman I, Mimouni F, Erlichman M, Schimmel M. Thyroxine-Based Screening for Congenital Hypothyroidism in Neonates with Down Syndrome. The Journal of Pediatrics. 2016; 173:165-168.
19. McGovern M, Reyani Z, O’Connor P. White M, Miletin J. Thyroid function testing in neonates born to women with hypothyroidism. European Journal of Pediatrics. 2016; 175(12):2015-2018.
20. Park E, Yoon J. Factors associated with permanent hypothyroidism in infants with congenital hypothyroidism. BMC Pediatrics. 2019; 19(1).
21. ALZobaidy MA, AlbuRghaif AH, Alhasany HA, Naji MA. Angiotensin-Converting Enzyme Inhibitors May Increase Risk of Severe COVID-19 Infection. Annals of the Romanian Society for Cell Biology. 2021; 16; 25(6):17843-9.
22. Zimmerman R, Pal D, Tin A, Ahsan H, Greenberg D. Methods for Assessing Familial Aggregation: Family History Measures and Confounding in the Standard Cohort, Reconstructed Cohort and Case-Control Designs. Human Heredity. 2009; 68(3):201-208.
23. Al-Hussaniy HA, Alburghaif AH, Naji MA. Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions. Journal of Medicine and Life. 2021; 14(5):600-605
24. Mazahir FA, Khadora MM. A retrospective analysis of congenital anomalies in congenital hypothyroidism. Journal of Pediatric Endocrinology and Metabolism. 2020 1; 33(9):1147-53.
25. Al-hussaniy HA, Altalebi RR, Alburagheef A, Abdul-Amir AG. The Use of PCR for Respiratory Virus Detection on the Diagnosis and Treatment Decision of Respiratory Tract Infections in Iraq. J Pure Appl Microbiol. 2022; 16(1): 201-206.
26. Sanyal D, Bhattacharjee K. High thyroid-stimulating hormone level in down's syndrome: A mere resetting of hypothalamopituitary axis in subclinical hypothyroidism?. Indian Journal of Endocrinology and Metabolism. 202; 24(5): 406-409
27. Metwalley KA, Farghaly HS. Endocrinal dysfunction in children with Down syndrome. Annals of Pediatric Endocrinology & Metabolism. 2022; 27(1): 15–21
28. Akeel Naji H. The Psychosocial and Economic Impact of Uveitis in Iraq. RABMS. 2021; 7 (4): 207-215
29. Salih DJ, Bakir N, Eissa AA, Al-Allawi NA. Clinical and cytogenetic profile in patients with Down syndrome in Duhok province, Iraq. Medical Journal of Babylon. 2017; 14(2):389-401.
30. Elsayed S, Ibrahim O, Salah H, Mowafy M, Bolz H. Relation of cardiac dysfunction to thyroid stimulating hormone in children with Down syndrome. Eur. J. Hum. Genet. 2018; 26:262-3.
31. M. VijeyAanandhi, Meha John. The Role of Thyroid Dysfunction and The Importance of Conducting Regular Thyroid Function Tests in patients with PCOS: A Narrative Review. Research J. Pharm. and Tech 2018; 11(12): 5672-5674.
32. Rutika, B. Maske. Down Syndrome: A Literature Review. International Journal of Advances in Nursing Management. 2021; 9(3):328-1.
33. Al-Shimmran BA, M. Anwer Z, H. Al-Jarrah B. Levothyroxine therapy adequacy, dose estimation and vitamin D effect assessment in a sample of Iraqi female patients with different causes of hypothyroidism. Iraqi J Pharm Sci. 2020; 29(2):245–52. Available from: http://dx.doi.org/10.31351/vol29iss2pp245-252.
34. Dhivya S, Sukanya Gangopadhyay, Pradeep Kumar S, Gautam Sarkar. Serum creatinine and eGFR are affected in female hypothyroid patients with poor Thyroid control. Asian J. Pharm. Tech. 2020; 10(4):241-244.
35. Albassam NY, Mohammed A, Murtada S. Evaluation of community pharmacists knowledge, attitude and practice towards modified release dosage forms. Iraqi J Pharm Sci. 2022; 30(Suppl.):40–7. DOI: http://dx.doi.org/10.31351/vol30isssuppl.pp40-47
36. Jenishia M. Thyroid Disorders during Pregnancy. Int. J. Nur. Edu. and Research. 2020; 8(3):391-393.
37. Kunal B. Kapadia, Jigna S Shah, Parloop A Bhatt. Interlinking Between Altered Thyroid State and Development of Insulin Resistance: A Review. Research J. Pharmacology and Pharmacodynamics. 2011; 3(5): 234-240.
38. Al-hassany HA, Albu-rghaif AH, A. Naji M. Tumor diagnosis by genetic markers protein P-53, p16, C-MYC, N-MYC, protein K-Ras, and gene her-2 Neu is this possible?. Pakistan Journal of Medical and Health Sciences. 2021;15(8):2350–4. Available from: http://dx.doi.org/10.53350/pjmhs21158235040.
39. Al-Hussaniy HA, Al-Kuraishy HM, Abdulameer AG. The Use of Panax Ginseng to Reduce the Cardiotoxicity of Doxorubicin and Study its Effect on Modulating Oxidative Stress, Inflammatory, and Apoptosis Pathways. Open Access Macedonian Journal of Medical Sciences. 2022;10(A):715-9.
40. Al-kuraishy AA, Jalil HJ, Mahdi AS, Al-hussaniy HA. General anesthesia in patient with Brain Injury. Medical and Pharmaceutical Journal. 2022;1(1):24-34. https://doi.org/10.55940/medphar20224
41. Abdulameer AA, Mohammed ZN, Tawfeeq KT. Endoscopic characteristics and management of Subepithelial Lesions in Video-Gastascopie. Medical and Pharmaceutical Journal. 2022; 1(1):4-13. https://doi.org/10.55940/medphar20222
42. Al-hussaniy HA, Altalebi RR, Tylor FM, Alwash AH, Naji MA, Kadhim ZS, Abu-rghaif AR. Leptin Hormone: In Brief. Medical and Pharmaceutical Journal. 2022;1(1):1-3. https://doi.org/10.55940/medphar20221
43. Naji MA, Alburghaif AH, Saleh NK, Al-hussaniy HA. Patient expectations regarding consultation with a family doctor: a cross-sectional study. Medical and Pharmaceutical Journal. 2022;1(1):35-40. https://doi.org/10.55940/medphar20225
44. Al-hussaniy H, Al-tameemi ZS. Methicillin-Resistant Staphylococcus aureus and New Delhi Metallo beta-lactamases-types of antibiotic resistance, methods of prevention. Medical and Pharmaceutical Journal. 2022; 1(1):14-24. https://doi.org/10.55940/medphar20223
45. Klyuev, S. A., Goremykin, I. V., Masevkin, V. G., Gorodkov, S. Y., Nikolaev, A. V., Shintaev, T. K., and Azizoğlu, M. Acute Gastric Dilation with Necrosis: Case Report And Literature Review. Journal of Clinical Trials and Experimental Investigations, 1(2), 32–46. https://doi.org/10.5281/zenodo.7007932
46. Al-Kuraishy HM, Al-Hussaniy HA, Al-Gareeb AI, Negm WA, El-Kadem AH, Batiha GE, Welson NN, Mostafa-Hedeab G, Qasem AH, Conte-Junior CA. Combination of Panax ginseng CA Mey and Febuxostat Boasted Cardioprotective Effects Against Doxorubicin-Induced Acute Cardiotoxicity in Rats. Frontiers in Pharmacology. 2022; 13.
47. Rutika, B. Maske. Down Syndrome: A Literature Review. International Journal of Advances in Nursing Management. 2021; 9(3):328-1
48. Angelin EA, Chellarani V, Shirley D, John M. Perception of Body Image and Sexuality of women with and without Systemic Lupus Erythematosus. Int. J. Nur. Edu. and Research. 2017; 5(4): 425-430.
49. Savitha P., Saravana Kumar S.2. Effect of Omega-3 Fatty acids on Memory – Review. Research J. Pharm. and Tech. 7(6): June, 2014;715-718.